Introduction {#s1}
============

Evolutionary novelties are qualitatively new traits that allow populations to invade previously inaccessible ecological niches ([@bib78]; [@bib56]). Novel traits are thus important drivers of speciation and adaptive radiations that promote biodiversity and ecological complexity. Indeed, many major transitions in evolution have been mediated by novel traits such as photosynthesis, multicellularity, endoskeletons, sociality, and cognition ([@bib55], [@bib49], [@bib25]; [@bib26]).

We previously proposed a model in which novel traits can evolve in three distinct phases ([@bib8]). In the potentiation phase, mutations accumulate in a lineage that make it possible to evolve the trait. In the actualization phase, a specific mutation produces the trait. Newly evolved traits are typically weak and ineffective. However, if the new trait confers even a slight advantage, it may spread throughout a population and, in the refinement phase, be improved by natural selection acting on subsequent mutations.

While potentiation and actualization enable the emergence of a novel trait, the capacity for refinement affects the trait's long-term persistence and potential to influence subsequent evolution ([@bib71]; [@bib24]). Prospects for refinement depend on the capacity to generate heritable phenotypic variation that can improve the trait and integrate it with other aspects of organismal performance ([@bib37]; [@bib64]), a facet of evolvability that we call 'refinement potential'.

Refinement potential is likely crucial for a population's long-term success in a new niche. A novel trait might allow a lineage to discover a new niche, but it does not guarantee long-term persistence. The new conditions may expose the population to selection pressures that differ in important respects from those of its ancestral niche, resulting in a mismatch between the organism and its environment ([@bib92]; [@bib76]; [@bib32]). Successful establishment can depend on ameliorating this mismatch ([@bib15]; [@bib83]), and failure to further adapt may lead to invasion failures ([@bib93]). Adaptation to a new niche therefore reflects a tension between evolvability and robustness ([@bib44]). The benefits of refining a novel trait must outweigh the costs (if any) of integrating that trait into organismal physiology.

Adaptation to novel niches has been widely studied in the context of invasive species that colonize and adapt to unfamiliar environments ([@bib19]; [@bib50]; [@bib48]). However, the ongoing refinement of traits that provide access to novel niches has received little attention, probably because most evolutionary novelties (and associated niche discoveries) occurred in the distant past and are therefore difficult to study. Experimental evolution allows researchers to overcome this challenge. It is possible to study evolutionary novelties that arise during experiments with microbial ([@bib7]; [@bib72]; [@bib4]; [@bib36]) and digital ([@bib43]) systems, in which evolution can be studied in real-time.

One such system is the Long-Term Evolution Experiment with *Escherichia coli* (LTEE), in which 12 bacterial populations founded from a common ancestral strain have been propagated for \>70,000 generations in a glucose-limited minimal medium, DM25 ([@bib42]). DM25 also contains abundant citrate, which serves as an iron-chelating agent ([@bib9]). Many bacteria can grow aerobically on citrate, but most *E. coli* strains cannot because they are unable to transport citrate into the cell ([@bib38]; [@bib31]; [@bib73]; [@bib67]).

Citrate was unexploited as a carbon and energy source in all of the LTEE populations until a Cit^+^ variant evolved in the population designated Ara−3 after \~31,000 generations ([@bib7]). The Cit^+^ trait arose in one of three coexisting lineages in this population by a genetic duplication that activated a previously unexpressed di- and tricarboxylate transporter ([@bib8]). The benefit of this duplication mutation was contingent, at least in part, on that lineage's prior evolution of an enhanced ability to use acetate excreted into the medium as a byproduct of glucose metabolism. That enhanced ability resulted from a mutation in citrate synthase that altered carbon flow into the tricarboxylic acid cycle in a manner that was pre-adaptive for growth on citrate ([@bib71]). Concurrently, the supply of competing beneficial mutations of large effect declined over time in the LTEE, allowing the Cit^+^ lineage to escape competitive exclusion ([@bib47]). The Cit^+^ trait radically altered this population's ecology and subsequent evolution ([@bib7]; [@bib8]; [@bib71]; [@bib70]; [@bib85]; [@bib86]). Access to the large citrate pool in the medium led to a several-fold increase in population size ([@bib7]). Nonetheless, a Cit^−^ lineage stably coexisted with the new Cit^+^ lineage for some 10,000 generations, before finally going extinct ([@bib7]; [@bib8]; [@bib85]; [@bib86]). Even after 70,000 generations, none of the other 11 populations in the LTEE have evolved the ability to use the available citrate ([@bib10]).

The emergence of Cit^+^ in the LTEE provides a powerful model system for studying the process of evolutionary innovation. Cit^+^ variants can grow not only in DM25, which contains both glucose and citrate, but also in DM0, a citrate-only medium in which *E. coli* normally cannot grow. How would the Cit^+^ trait be refined if these variants colonized and adapted to this newly accessible citrate-only environment? To address this question, we founded 12 new, initially clonal Cit^+^ populations and allowed them to evolve in DM0 for 2500 generations. We also allowed a second set of 12 populations to evolve in the original DM25 medium for comparison. We sequenced the genomes of evolved clones sampled from all 24 populations to find parallel genetic changes that indicate likely targets of selection ([@bib80]; [@bib21]). Among other parallel changes, we identified numerous IS element insertions and several large gene amplifications. Our results thus show that genomic structural variation involving transposable elements and amplifications can provide a rich source of plasticity and potential for novel trait refinement and adaptation to new niches.

We also compared the growth of the DM0-evolved clones to that of their ancestors in both DM0 and DM25, and we examined fitness changes at the level of both whole populations and individual clones. Although all populations show substantial adaptation reflected in their growth parameters, we also found evidence of persistent maladaptation, suggesting that this new function poses metabolic challenges that are difficult to overcome evolutionarily. Some individual evolved clones grow more poorly than their ancestors, even in the medium in which they had evolved. The fitness assays show atypically large variation across replicate assays of evolved populations and clones, as well as some paradoxical apparent declines in fitness despite 2500 generations of evolution. We also observed high levels of cell death in the ancestral and evolved Cit^+^ clones that we examined. This experimental system thus sheds light not only on how new traits are refined during adaptation to a novel niche, but also on how maladaptive phenotypes may persist for long periods in new environments.

Results {#s2}
=======

Experimental design and phylogenetic analysis of sequenced strains {#s2-1}
------------------------------------------------------------------

We isolated three Cit^+^ clones (CZB151, CZB152, and CZB154) from the 33,000-generation sample of the Ara−3 population, and derived spontaneous Ara^+^ revertants of each clone (ZDB67, ZDB68, and ZDB69, respectively). We used each of the six clones to found two populations that evolved in the citrate-only medium (DM0) for 2500 generations and two populations that evolved for 2500 generations in the medium containing both glucose and citrate (DM25) as a control ([Figure 1](#fig1){ref-type="fig"}). Evolved clones were isolated from each of the 24 populations at the end of the experiment, and we sequenced their genomes along with those of the six founding clones. We used these data to identify mutations that had accumulated during the evolution experiment.

![Experimental design and sequenced clone derivations.\
We isolated three Cit^+^ clones (red hexagons) from generation 33,000 of LTEE population Ara−3. We then derived Ara^+^ mutants (white hexagons) from those three LTEE clones. We used these six clones to found 24 populations. Twelve populations evolved for 2500 generations in citrate-only medium, DM0 (cyan lines). The remaining 12 evolved for 2500 generations in glucose and citrate medium, DM25 (black lines). The evolved clones we isolated after 2500 generations for genomic and phenotypic analysis are shown for each population.](elife-55414-fig1){#fig1}

We also used the genomic data to verify the presumed phylogenetic relationships among the ancestral (including the Ara^+^ revertants) and evolved clones, in the context of the Cit^+^ lineage of the Ara−3 population. This analysis showed that CZB154 is one mutation off the line of descent for the post-33,000 generation Cit^+^ lineage in the Ara−3 population, as it subsequently evolved in the LTEE ([@bib8]). That mutation is a 1 bp deletion (GGGGGG → GGGGG) in the promoter of the hypothetical protein-coding gene ECB_03525. CZB151 does not have that mutation, but it possesses all of the other mutations found in the CZB154 clone, as well as two additional mutations. One is a C→G transversion that causes a nonsynonymous E181K mutation in the *insD* transposase. The other is a deletion of a CGCGG repeat that restores both the reading frame and function to the pseudogene *dcuS* ([@bib85]). The restored gene encodes a histidine kinase that regulates anaerobic fumarate respiration ([@bib81]; [@bib34]). CZB152, by contrast, belongs to a lineage somewhat farther from the eventual line of Cit^+^ descent in the Ara−3 population, and it differs from CZB151 and CZB154 by several mutations ([@bib8]). Genomic analysis also showed that the Ara^+^ revertant ZDB67 differs from its parent clone, CZB151, only in the expected restoration-of-function mutation in the *araA* gene. The Ara^+^ revertants ZDB68 and ZDB69 have secondary mutations relative to CZB152 and CZB154, respectively, in addition to the expected mutation in *araA*. ZDB68 has a C→G transversion that introduces a nonsynonymous T33I mutation in *yfcC*, which encodes a predicted inner-membrane protein; and ZDB69 has a 1 bp deletion in *nplI,* which encodes a hypothetical protein of unknown function. All 24 evolved clones evolved in DM0 or DM25 have the mutations that are unique to their ancestors. Therefore, no cross-contamination that would compromise the independence of the evolved lines took place during the experiment.

One evolved clone from population DM0−2, ZDBp874, lacks the *citT* amplification that confers the Cit^+^ trait ([@bib7]; [@bib8]). That clone also displays a negative reaction on Christensen's Citrate agar, confirming a Cit^−^ phenotype. We therefore sequenced the genome of a second isolate, ZDBp875, from the same population. We verified that ZDBp875 has the Cit^+^ trait. The ZDBp874 and ZDBp875 genomes share only a single derived mutation, an IS*150* insertion at the −35 position of the promoter of *yhiO*, which encodes universal stress protein B (UspB). The two clones thus appear to belong to coexisting lineages that diverged early during their evolution in DM0. We did not discover any additional Cit^−^ variants in the DM0−2 population during a phenotypic screen of several hundred clones. Previous work has shown that the *citT* amplifications are prone to spontaneous collapse back to a single copy ([@bib8]). This collapse, which presumably occurs by homologous recombination, eliminates CitT expression and causes reversion to the Cit^−^ phenotype. The ZDBp874 clone could be either a recent and fortuitously sampled 'amplification collapse' mutant or a representative of a rare and stably coexisting Cit^−^ lineage in that population.

Genome evolution is faster in the citrate-only environment than in the control environment {#s2-2}
------------------------------------------------------------------------------------------

The populations that evolved in the citrate-only DM0 medium accumulated more mutations than those that evolved in DM25, which contains both glucose and citrate ([Figure 2A](#fig2){ref-type="fig"} vs. [Figure 2B](#fig2){ref-type="fig"}). The DM0-evolved genomes had an average of 19.5 mutations, whereas the DM25-evolved genomes had an average of 13.7 mutations (Mann-Whitney two-tailed test, p=0.0116). The DM0 genomes had an average of 3.1 nonsynonymous SNPs in protein-coding genes, as compared to 1.1 on average for the DM25 genomes. The DM0 genomes also had more IS insertions on average than the DM25 genomes (10.3 vs. 6.6), driven largely by IS*150* insertions (8.5 vs. 4.9). The evolved genomes from the DM0 and DM25 treatments had similarly low average numbers of synonymous mutations (0.1 vs. 0.3), deletions (3.8 vs. 3.8), non-IS insertions (0.8 vs. 0.8), consecutive bp-substitutions (0.1 vs. 0.1), and SNPs outside of coding regions (1.4 vs. 1.1). The nearly identical numbers of synonymous mutations and SNPs outside protein-coding genes that we see in genomes evolved in DM0 and DM25 imply that the disparities in nonsynonymous mutations and IS insertions between the two conditions were, at least in part, driven by stronger selection in DM0, as opposed to a higher mutation rate or differences in population dynamics caused by the more stressful DM0 environment ([@bib28]).

![Numbers and types of mutations in evolved genomes.\
(**A**) Evolved genomes from the DM0 treatment after 2500 generations. (**B**) Evolved genomes from the DM25 treatment after 2500 generations. (**C**) Evolved genomes in the 10 non-hypermutable LTEE populations after 5000 generations. Mutations are color-coded according to the key: indel, insertions and deletions (excluding large duplications and amplifications); intergenic, intergenic point mutations; mobile-element transpositions; multiple-base substitution, consecutive point mutations (including adjacent to and in conjunction with indels); nonsense, nonsynonymous, and synonymous point mutations in protein-coding genes; pseudogene, mutations in pseudogenes.\
Figure 2---source data 1.All evolved mutations found in the DM0-treatment and DM25-treatment clones.\
Figure 2---source data 2.Classification and counts of mutations in the 264 LTEE genomes, originally published as Supplementary Table 4 of [@bib80].](elife-55414-fig2){#fig2}

In both resource environments, the spectrum of mutations identified in evolved clones was dominated by structural variation, including insertions, deletions, and mobile element transpositions ([Figure 2A,B](#fig2){ref-type="fig"}). This spectrum is quite different from that observed in the LTEE populations. [Figure 2C](#fig2){ref-type="fig"} shows the number and spectrum of mutations in clones isolated from 10 LTEE populations after 5000 generations (two other populations had evolved point-mutation hypermutability and are not shown). Despite having evolved for twice as many generations, the LTEE clones have roughly similar numbers of mutations as observed in our experiments. The mutational spectrum was dominated by nonsynonymous point mutations in all but one of the LTEE populations, Ara+1. The mutation spectrum in our study is similar to that particular population, which evolved an elevated rate of IS*150* transposition early in its history ([@bib61]; [@bib80]). It is also similar to that of a sub-lineage within another LTEE population, Ara−5, which also evolved IS*150*-mediated hypermutability, but much later in that experiment ([@bib80]). Most clones from the DM0 and DM25 treatments also have more deletions than the LTEE clones, again despite having evolved for fewer generations. These differences suggest some genomic instability in our study populations, in addition to the high rates of IS*150* transposition.

Fitness changes after 2500 generations in DM0 and DM25 environments {#s2-3}
-------------------------------------------------------------------

We conducted competition assays with evolved population samples to measure their fitness in DM0 and DM25 ([@bib42]). We had difficulty in obtaining neutral derivatives of ancestral clones with the opposite Ara marker state, possibly due to genomic instability. We therefore used CZB151 as a common competitor for the Ara^+^ populations and ZDB67 for the Ara^−^ populations. Regardless of the environment in which they evolved, the populations display high variance across replicates in DM0 ([Figure 3A](#fig3){ref-type="fig"}), and most exhibit high variance across replicates in DM25 ([Figure 3B](#fig3){ref-type="fig"}). Eight of the 12 DM0-evolved populations have average fitness values in DM0 higher than their respective ancestral controls, but owing to the high variances, only two cases (DM0--6, DM0+6) appear compelling. Even in DM25, where the variances are less extreme, only two DM25-evolved populations (DM25--5, DM25--6) appear a bit more fit than their ancestors, while some DM0-evolved populations (DM0--1, DM0--2, DM0--5) were clearly less fit in DM25.

![Fitness of evolved populations and their Cit^+^ ancestors relative to Cit^+^ ancestral clones CZB151 and ZDB67 in DM0 and DM25.\
To show the difference in scale across panels, dashed gray lines are drawn at 1.0 (neutrality) and 1.5 on the y-axis. Ancestral strain CZB151 and its descendants are shown in black, CZB152 and its descendants are in orange, and CZB154 and its descendants are in blue. (**A**) Fitness of evolved and ancestral populations relative to CZB151 and ZDB67 in DM0, as measured in one-day competition assays. Some confidence limits extend beyond the range shown on the y-axis. (**B**) One-day fitness of evolved and ancestral populations relative to CZB151 and ZDB67 in DM25, as measured in one-day competition assays. Error bars are 95% confidence intervals. \
Figure 3---source data 1.Colony counts for fitness competitions of evolved populations in DM0 growth medium (Panel A).\
Figure 3---source data 2.Colony counts for fitness competitions of evolved populations in DM25 growth medium (Panel B).](elife-55414-fig3){#fig3}

We also examined fitness changes in evolved clones relative to their direct ancestors. We only tested clones from populations for which we were able to obtain neutral ancestral variants with the opposite Ara marker state. We saw much lower variability across the clonal replicates than we did for the whole population samples. This reduced variance may reflect in part the higher replication and longer duration of the assays using clones; it might also be the case that the within-population genetic variation led to greater variation in the outcome of the whole-population competition assays. Nonetheless, we still saw inconsistent and paradoxical fitness changes in some clones. Two DM0-evolved clones (ZDBp880 and ZDBp886) were substantially less fit than their ancestors in DM0. All DM25-evolved clones except ZDBp913 were also less fit in DM0 ([Figure 4A](#fig4){ref-type="fig"}). In DM25, one DM0-evolved clone (ZDBp880) and one DM25-evolved clone (ZDBp915) were clearly less fit than their ancestors ([Figure 4B](#fig4){ref-type="fig"}).

![Fitness of select evolved clones against their direct ancestors in DM0 and DM25.\
The dashed grey line shows neutrality. Ancestral strain CZB151 and its descendants are shown in black, CZB152 and its descendants are in orange, and CZB154 and its descendants are in blue. (**A**) Fitness of evolved clones relative to their direct ancestors in DM0 in a three-day competition assay. (**B**) Fitness of evolved clones relative to their direct ancestors in DM25 in a three-day competition assay. Error bars are 95% confidence intervals. We selected clones for fitness assays based only on the availability of ancestral genotypes with confirmed, neutral, opposing Ara marker states.\
Figure 4---source data 1.Colony counts for fitness competitions of evolved clones in DM0 growth medium (Panel A).\
Figure 4---source data 2.Colony counts for fitness competitions of evolved clones in DM25 growth medium (Panel B).](elife-55414-fig4){#fig4}

Changes in growth parameters after 2500 generations in DM0 and DM25 environments {#s2-4}
--------------------------------------------------------------------------------

To assess changes in growth parameters at the end of the evolution experiment, we compared the growth curves of evolved populations and clones to those of their respective ancestors (Figures 5--9). To quantify changes in growth parameters more precisely, we estimated the slope of the log-transformed growth curves over two separate intervals in DM25. In this medium, the Cit^+^ bacteria undergo an apparent diauxic shift from growth on glucose to growth on citrate. Therefore, we chose intervals of optical density (OD) in which the change in OD over time would correspond to the respective growth rates on those resources. We also estimated the duration of the lag prior to initial growth on glucose. A schematic of this method is shown in [Figure 5](#fig5){ref-type="fig"}. We calibrated the relevant intervals based on the growth kinetics of two Cit^−^ strains in DM25: the founding LTEE strain, REL606 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), and the anomalous evolved clone, ZDBp874 ([Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [2](#fig7s2){ref-type="fig"}). In DM0, we estimated the duration of the lag phase and the growth rate on citrate only.

![Schematic of the log-slope method to calculate growth rates.\
We log*~e~*-transformed optical densities, and used the slope of the curve in the interval OD~420\ nm~ = \[0.01, 0.02\] to calculate the exponential growth rate on glucose (h^−1^), *r~glucose~*. We used the slope of the curve in the interval OD~420\ nm~ = \[0.05, 0.1\] to calculate the exponential growth rate on citrate (h^−1^) *r~citrate~*. In making this interpretation, we assumed a diauxic shift between growth on glucose and citrate, rather than simultaneous growth on both substrates. In any case, growth rates during these intervals are relevant phenotypes even without assuming diauxie. We estimated lag time (τ) as the time (h) until OD~420\ nm~ = 0.01 was reached.](elife-55414-fig5){#fig5}

On balance, the populations evolved higher exponential growth rates and shorter lag phases in both DM0 and DM25. These demographic changes are consistent with those observed in the LTEE ([@bib89]). Indeed, all DM0-evolved populations show improvements in their growth on citrate in both DM0 and DM25 ([Figure 6](#fig6){ref-type="fig"}), whereas their growth on glucose in DM25 shows little or no change. In DM0, the populations also exhibit markedly reduced lags prior to commencing growth ([Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}).

![Growth parameters for whole-population samples that evolved in DM0 and their Cit^+^ ancestors.\
(**A**) Estimates of various growth parameters for the ancestral strains and DM0-evolved populations at 2500 generations, using the log-slope method. Ancestral strain CZB151 and its descendants are shown in black, CZB152 and its descendants are in orange, and CZB154 and its descendants are in blue. Units for growth rates are h^−1^, and units for lag times are h. Bias-corrected and accelerated (*BC~a~*) bootstrap 95% confidence intervals around parameter estimates were calculated using 10,000 bootstraps. (**B**) Estimates of log~2~-transformed ratios of growth parameters for the evolved populations and their ancestors. The growth curves we used to estimate these parameters are shown in [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}.\
Figure 6---source data 1.Optical density (420 nm) timeseries for DM0-evolved populations and their ancestors in DM0 and DM25 growth media.](elife-55414-fig6){#fig6}

We observed substantially more variation in growth parameters among the evolved clones ([Figures 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}) than among the whole-population samples from which they were isolated. In fact, some evolved clones grow more poorly than their ancestors, as shown by non-overlapping confidence intervals on their growth parameter estimates in [Figure 7A](#fig7){ref-type="fig"}. Two CZB151-derived, DM0-evolved clones, ZDBp871 and ZDBp889, show little or no improvement in DM0, and they are markedly worse than CZB151 in DM25. Similarly, the anomalous Cit^−^ clone, ZDBp874, is not only unable to grow in DM0, but also grows much more poorly than its ancestor in DM25 ([Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [2](#fig7s2){ref-type="fig"}). All other DM0-evolved clones grow better than their ancestors in DM0, and most also grow about as well as their ancestors in DM25, with the additional exception of ZDBp901.

![Growth parameters for clones from populations that evolved in DM0 and their Cit^+^ ancestors.\
(**A**) Estimates of growth parameters for the ancestral strains and DM0-evolved clones sampled at 2500 generations, using the log-slope method. CZB151 and its descendants are in black, CZB152 and its descendants are in orange, and CZB154 and its descendants are in blue. (**B**) Estimates of log~2~-transformed ratios of growth parameters for the evolved clones and their ancestors. The growth curves we used to estimate parameters are shown in [Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [2](#fig7s2){ref-type="fig"}. We excluded the anomalous evolved Cit^−^ clone. See [Figure 6](#fig6){ref-type="fig"} for additional details.\
Figure 7---source data 1.Optical density (420 nm) timeseries for DM0-evolved clones and their ancestors in DM0 and DM25 growth media.](elife-55414-fig7){#fig7}

![Growth parameters of the 12 DM25-evolved clones and their 3 Cit^+^ ancestors.\
(**A**) Estimates of growth parameters for each ancestral and DM25-evolved clone, using the log-slope method ([Figure 2](#fig2){ref-type="fig"}). Estimates for ancestral strain CZB151 and its descendants are shown in black, estimates for CZB152 and its descendants are in orange, and estimates for CZB154 and its descendants are in blue. Units for growth rates *r* are h^−1^, and units for lag times are h. Bias-corrected and accelerated (*BC~a~*) bootstrap 95% confidence intervals around parameter estimates were calculated using 10,000 bootstraps; no confidence interval is shown if a parameter could not be estimated accurately from the available data. Aberrant estimates that fall outside of these ranges are not shown. (**B**) Estimates of log~2~-transformed ratios of growth parameters for the evolved clones and their ancestors. The growth curves used to estimate these parameters are shown in [Figure 8---figure supplements 1](#fig8s1){ref-type="fig"} and [2](#fig8s2){ref-type="fig"}.\
Figure 8---source data 1.Optical density (420 nm) timeseries for DM25-evolved clones and their ancestors in DM25 growth medium.](elife-55414-fig8){#fig8}

Our finding that some evolved clones are significantly less fit than their ancestor, along with the differences in the growth parameters of the evolved clones and the whole populations, implies that ecologically relevant genetic variation exists in both the DM0- and the DM25-evolved populations. We therefore considered the possibility that improved growth performance on citrate always comes at a cost of reduced growth on glucose. We used our separate estimates of growth rates on glucose and citrate in DM25 to determine if growth on the two substrates was correlated. However, we found no significant correlation between growth rates on citrate and glucose for either the DM0-evolved clones or whole populations ([Figure 9A](#fig9){ref-type="fig"}). By contrast, the growth rates measured on citrate in the two media, DM0 and DM25, are highly correlated for both clones and populations ([Figure 9B](#fig9){ref-type="fig"}).

![Correlations between estimated growth rates across substrates and media for DM0-evolved clones and populations.\
All tests are two-tailed, because growth rates across substrates and media might, in principle, exhibit tradeoffs. (**A**) Correlations between *r~glucose~* and *r~citrate~* in DM25 are not significant (Pearson's *r* = 0.4788, d.f. = 12, p=0.0833 for clones; *r* = --0.0392, d.f. = 13, p=0.8897 for populations). (**B**) Correlations between *r~citrate~* in DM0 and *r~citrate~* in DM25 are highly significant (*r* = 0.7513, d.f. = 12, p=0.0020 for clones; *r* = 0.8041, d.f. = 13, p=0.0003 for populations). Circles and triangles indicate ancestral and evolved samples, respectively. Colors distinguish the different Cit^+^ ancestors and their evolved descendants.\
Figure 9---source data 1.Optical density (420 nm) timeseries for DM0-evolved populations and their ancestors in DM0 and DM25 growth media.\
Figure 9---source data 2.Optical density (420 nm) timeseries for DM0-evolved clones and their ancestors in DM0 and DM25 growth media.](elife-55414-fig9){#fig9}

Evidence of cell death in clones isolated from both DM0 and DM25 environments {#s2-5}
-----------------------------------------------------------------------------

The contribution of cell death to fitness in the LTEE is generally negligible compared to that of growth ([@bib89]). However, we serendipitously discovered evidence of substantial cell death in cultures of a Cit^+^ clone sampled from the Ara−3 population of the LTEE at 50,000 generations. This observation led us to examine the relationship between the Cit^+^ trait and cell death in more detail by using fluorescence microscopy ([Figure 10](#fig10){ref-type="fig"}). We analyzed five clones: the LTEE ancestor, REL606; the 33,000-generation Cit^+^ clone, CZB151; one of its DM0-evolved descendants, ZDBp871; one of its DM25-evolved descendants, ZDBp910; and the 50,000-generation Cit^+^ clone, REL11364. We labeled cells from 24 hr stationary-phase cultures (i.e., when they would be transferred to fresh medium in the evolution experiment) using two-color live/dead stains (Materials and methods).

![Elevated mortality in Cit^+^ strains.\
The Cit^+^ strains exhibit substantially elevated mortality in the citrate-only DM0 medium; some also show high mortality in DM25 as well. REL606 is Cit^−^ and cannot grow in DM0. CZB151 was isolated from LTEE population Ara−3 at generation 33,000, and its descendants, ZDBp871 and ZDBp910, had evolved for 2500 generations in DM0 and DM25 media, respectively. REL11364 was isolated from LTEE population Ara−3 at generation 50,000. (**A**) Representative micrographs of the five clones in the two media. We stained cells using the *Bac*Light Viability Kit, and we scored them as dead if their red fluorescence exceeded their green fluorescence (see Materials and methods). Scale bars (lower right corner) represent 5 μm. (**B**) Proportion of dead cells in five replicate cultures of each strain grown in DM0 and DM25 medium each (except for ZDBp910, with only one replicate). The wider symbols show estimated overall proportions weighted by the number of cells analyzed in each replicate culture. We calculated bias-corrected and accelerated (*BC~a~*) bootstrap 95% confidence intervals using 10,000 bootstraps (except for ZDBp910), and we weighted by the number of cells analyzed in each replicate.\
Figure 10---source data 1.Cell death estimates.\
Figure 10---source data 2.Micrograph image segmentation and classification by SuperSegger software, part 1.\
Figure 10---source data 3.Micrograph image segmentation and classification by SuperSegger software, part 2.](elife-55414-fig10){#fig10}

Proportions of dead cells were calculated for five independent cultures for each clone and medium combination (except ZDBp910, for which we had problems with growth in DM0 and so have only one replicate, and REL606, which cannot grow in DM0). [Figure 10A](#fig10){ref-type="fig"} shows representative fields for each clone in DM0 and DM25. [Figure 10B](#fig10){ref-type="fig"} shows the resulting estimates of the proportion of dead cells, along with 95% bias-corrected and accelerated (*BC~a~*) bootstrap confidence intervals ([@bib23]) weighted by the number of cells analyzed and scored in the replicate cultures. On average, 10.7% of the LTEE ancestral cells grown in DM25 were scored as dead in stationary phase. By contrast, when grown in the same DM25 medium, 29.6% and 39.9% of cells were scored as dead for the Cit^+^ clones isolated from LTEE population Ara−3 at 33,000 (CZB151) and 50,000 generations (REL11364), respectively. We observed similarly high proportions of dead cells for both clones in DM0 as well (33.1% and 44.2% for CZB151 and REL11364, respectively). These results indicate that the evolution of aerobic growth on citrate in the LTEE was associated with elevated mortality. Moreover, the increased mortality was not remedied even after almost 20,000 generations since the new trait arose in the Ara−3 population. The two evolved clones we examined from our evolution experiment, ZDBp871 and ZDBp910, show somewhat different patterns. Both show lower mortality in glucose-containing DM25 (25.3% and 12.4% for ZDBp871 and ZDBp910, respectively) but higher mortality in citrate-only DM0 (53.0% and 51.6% for ZDBp871 and ZDBp910, respectively). The reduced mortality of ZDBp910 in DM25, in which it evolved for an additional 2500 generations, suggests that the apparent metabolic imbalance associated with growth on citrate may be reduced by evolving in a medium that also contains glucose. It is even more surprising, then, that we observed no comparable reduction in mortality in the 50,000-generation Ara−3 clone, which might indicate that historically contingent ecological and genetic interactions are important for this trait. Moreover, the very high death rate of ZDBp871 in DM0, the medium in which it evolved, suggests that correcting the metabolic imbalance is even more difficult when citrate is the sole carbon and energy source.

Specificity of genome evolution in the DM0 and DM25 environments {#s2-6}
----------------------------------------------------------------

We found evidence that the DM0 and DM25 environments selected for mutations in different genes. Following [@bib21], we compared the distribution of 'qualifying' mutations---nonsynonymous SNPs, deletions, duplications, and IS insertions that unambiguously affect single genes---that arose during evolution in each medium. We identified all genes in which we found at least two qualifying mutations across the 24 evolved Cit^+^ clones we sequenced. These genes are shown in [Figure 11](#fig11){ref-type="fig"}, where they are ranked by the absolute value of the difference in the number of qualifying mutations between the DM0 and DM25 conditions.

![Parallel genetic evolution.\
Genes with mutations in two or more sequenced genomes from the DM0- and DM25-evolved populations, ranked by the absolute value of the difference in the number of qualifying mutations (see main text) between DM0 and DM25. Mutations in the same genes in the six non-mutator LTEE lineages and in a Cit^+^ clone from LTEE population Ara−3 (which evolved hypermutability), all at 50,000 generations, are shown for comparison. Yellow, violet, or red fill indicates the presence of one, two, or three qualifying mutations, respectively. Mutation details are provided in [Supplementary file 5](#supp5){ref-type="supplementary-material"}.\
Figure 11---source data 1.Counts of qualifying mutations in evolved clones.\
Figure 11---source data 2.Presence/absence of *dctA* and *maeA* amplifications in evolved clones.\
Figure 11---source data 3.Counts of qualifying mutations in non-mutator LTEE 50,000 generation clones.](elife-55414-fig11){#fig11}

We then used the method of [@bib21] to quantify the extent of parallelism in genome evolution within and between the DM0 and DM25 treatments. We computed Dice's Coefficient of Similarity, *S*, for each pair of evolved clones, where $S = 2\left| {X \cap Y} \right|/\left( {\left| X \right| + \left| Y \right|} \right)$. $\left| X \right|$ and $\left| Y \right|$ are the cardinalities of the sets of genes with qualifying mutations in two clones, and $\left| {X \cap Y} \right|$ is the cardinality of the set of genes with mutations in both clones. *S* thus ranges from 0, when the two clones have no qualifying mutations in common, to 1, when both clones have qualifying mutations in exactly the same set of genes. The grand mean similarity, *S~m~*, is 0.135 across the 24 evolved clones. The mean within-treatment similarity, *S~w~*, is 0.177, meaning that two clones that evolved independently in the same medium on average have 17.7% of mutated genes in common. By contrast, the mean between-treatment similarity, *S~b~*, is 0.096, meaning that two clones that evolved in different media on average have only 9.6% of mutated genes in common. We evaluated the significance of the difference between *S~w~* and *S~b~* using a randomization test in which clones were permuted across samples 10,000 times, and the difference between the two measures was calculated for each permutation. The observed difference between the DM0- and DM25-evolved clones was higher than in any of the permutations. The greater genomic parallelism within than between environments is therefore highly significant (*p* \< 0.0001).

Five genes had significantly more parallel mutations in one environment than in the other. Eleven of the 12 DM0-evolved Cit^+^ clones had qualifying mutations associated with *yhiO*, encoding the universal stress protein UspB, compared to 4 of 12 clones that evolved in DM25 (Fisher's exact test: p=0.0094). Similarly, we found qualifying mutations in *gltA*, which encodes citrate synthase, in 11 of the DM0-evolved Cit^+^ clones, whereas only 3 of the DM25-evolved clones had mutations in that gene (Fisher's exact test: p=0.0028). The gene encoding isocitrate lyase, *aceB*, had only one qualifying mutation among the DM0-evolved genomes, but nine in the DM25-evolved genomes (Fisher's exact test: p=0.0028). Among the DM0-evolved genomes, there are no qualifying mutations in *menC*, which encodes O-succinylbenzoate synthase, but 5 DM25-evolved genomes have mutations in that gene (Fisher's exact test: p=0.0373). Six DM0-evolved genomes have qualifying mutations in the *fadL* gene, which encodes an outer membrane long-chain fatty acid channel, but none of the DM25-evolved genomes have mutations in this gene (Fisher's exact test: p=0.0137). Moreover, we found nine additional qualifying mutations associated with four other genes (*fadA*, *fadE*, *fadD*, and *fadR*) in the fatty-acid degradation regulon among the DM0-evolved genomes, but none in the DM25-evolved genomes. Mutations in the *fad* regulon thus show a strong signature of adaptation specific to the DM0 medium. Thirteen of the 15 qualifying mutations in the *fad* regulon were mobile-element insertions.

The environment was much more important than the ancestral genotype in determining the genetic targets of selection. We found no difference in the total number of qualifying mutations between the 24 evolved Cit^+^ clones when grouped by ancestor (i.e., CZB151, CZB152, CZB154) (Kruskal-Wallis test, p=0.8873). Moreover, by using the same randomization test described above to test the significance of the difference between *S~w~* and *S~b~*, we found no significant difference based on ancestral genotype (p=0.5540, based on 10,000 replicates).

We also found five instances of parallel changes at the amino-acid level among the DM0-evolved genomes. Three of the five occurred in *gltA*, which encodes citrate synthase: M172I, A162T, I114F. All three of these substitutions are near the allosteric binding pocket for NADH ([Figure 11---figure supplement 1](#fig11s1){ref-type="fig"}). [@bib71] reported an A162V substitution that likewise affects NADH binding, and which was previously shown to fine-tune carbon flux through citrate synthase ([@bib54]). These three *gltA* mutations presumably have similar effects. We also saw parallel I197L substitutions in *ygaF*, which encodes a protein that dehydrogenates L-2-hydroxyglutarate to alpha-ketoglutarate and replenishes the cell's reduction potential by feeding electrons from this reaction into the membrane quinone pool ([@bib35]). There were parallel S351C substitutions in *atoS* in ZDBp871 and the anomalous Cit^−^ clone ZDBp874. This gene encodes the sensor protein of a two-component regulatory system that stimulates short-chain fatty acid catabolism. Unlike some mutations that might reduce or destroy a protein's functionality, we expect that these parallel amino-acid substitutions fine-tune protein function ([@bib52]).

Contribution of transposable insertion elements to parallel evolution {#s2-7}
---------------------------------------------------------------------

Notwithstanding the parallel amino-acid substitutions described above, most of the parallel genomic evolution reflects the activity of IS elements. In both environments, most new IS insertions are copies of IS*150* elements ([Figure 12A and B](#fig12){ref-type="fig"}). We compared the number of IS*150* insertions in clones evolved in the two media to the number that had accumulated through 50,000 generations in the Ara−3 population of the LTEE ([Figure 12C](#fig12){ref-type="fig"}). The rates of IS*150* insertion accumulation in the Ara−3 population and the DM25-evolved Cit^+^ populations are comparable, but much lower than in the DM0-evolved populations. The difference between the DM0- and DM25-evolved genomes is significant (Mann--Whitney *U* test, two-tailed p=0.0089), despite the high variability between genomes within each group ([Figure 2A and B](#fig2){ref-type="fig"}).

![Parallel IS-element insertions.\
(**A**) Counts of parallel IS-element insertions in labeled genes (including promoter and coding regions) summed across sequenced DM0- and DM25-evolved genomes, and arranged by position on the *E. coli* chromosome, relative to the inferred last common ancestor of all strains (Materials and methods). IS*1* insertions are shown in pink, IS*150* in lavender, IS*186* in red, IS*3* in black, and IS*RSO11* in green. Some genes contain multiple sites with parallel IS-element insertions. (**B**) Location of insertions, shown separately for the DM0- and DM25-evolved genomes. Colors are the same as in panel A. (**C**) Total number of IS*150* insertions in the DM0- and DM25-evolved genomes after 2500 generations. The corresponding numbers of IS-element insertions in clones isolated from LTEE population Ara−3 at time points over 50,000 generations of evolution are shown for comparison. DM0 clones are labeled as brown circles, DM25 clones as pink triangles, and LTEE Ara−3 clones as tan squares.\
Figure 12---source data 1.Table of IS-element insertions in evolved genomes.\
Figure 12---source data 2.Table of IS-element insertions in LTEE and Mutation Accumulation Experiment (MAE) genomes, originally published in [@bib80].](elife-55414-fig12){#fig12}

Insertions of IS*150* into new sites were strongly parallel across the independently evolved populations within, but not between, the two environments ([Figure 12A and B](#fig12){ref-type="fig"}). These systematic differences led us to hypothesize that the parallel IS insertions reflect the influence of selection, rather than insertion-site biases ([Figure 11](#fig11){ref-type="fig"}, [Figure 12B](#fig12){ref-type="fig"}; [@bib80]). We evaluated this hypothesis by conducting a randomization test for selection-driven parallel IS*150* insertions over and above a null model that assumes only insertion-site preferences (Materials and methods). The most extreme observed case of parallelism at the base-pair level was an IS*150* insertion at the −35 position of the promoter for *yhiO*, which encodes the universal stress protein UspB, which happened in 9 of the 12 DM0 genomes (randomization test with 100,000 bootstraps: p=0.014). This test is even more conservative because it excludes two other IS*150* insertions affecting this same gene in the DM0 genomes: an IS*150* insertion at the −36 position of the promoter and another IS*150* insertion in *yhiO* itself. Therefore, we can reject the null hypothesis that site-specific insertion biases alone provide an adequate explanation for the distribution of IS*150* insertions. Given the conservative nature of this test, it is quite possible that some other parallel IS-insertions also indicate positive selection.

Parallel amplification mutations in the DM0- and DM25-evolved populations {#s2-8}
-------------------------------------------------------------------------

We detected tandem amplifications of large genomic regions, often to high copy-number, in many DM0- and DM25-evolved clones ([Tables 1](#table1){ref-type="table"} and [2](#table2){ref-type="table"}, [Figure 13](#fig13){ref-type="fig"}). All genomes include amplifications containing the novel genetic module that evolved during the LTEE, which places one or more copies of the *citT* gene under the control of the *rnk* promoter region, with the exception of the anomalous Cit^−^ clone ZDBp874 ([Table 1](#table1){ref-type="table"}). This new *rnk-citT* module provides access to citrate, and mutations that increase its dosage improve growth on citrate ([@bib8]; [@bib87]).

###### Copy number of amplified *citT* genes in sequenced clones.

Table 1---source data 1.Copy number of amplifications affecting *citT, dctA, and maeA* in the ancestral and evolved clones.

  Genome    Medium   Mean copy number   Minimum copy number^\*^   Maximum copy number^\*^
  --------- -------- ------------------ ------------------------- -------------------------
  CZB151    DM25     4.21               3.39                      5.47
  CZB152    DM25     8.23               5.17                      11.46
  CZB154    DM25     4.14               1.72                      9.83
  ZDBp871   DM0      2.82               1.70                      4.26
  ZDBp875   DM0      11.37              8.05                      14.93
  ZDBp877   DM0      7.68               3.66                      11.33
  ZDBp880   DM0      3.82               1.79                      5.93
  ZDBp883   DM0      5.08               1.88                      12.81
  ZDBp886   DM0      4.76               2.27                      6.88
  ZDBp889   DM0      4.66               2.90                      7.11
  ZDBp892   DM0      5.69               2.21                      8.76
  ZDBp895   DM0      5.30               2.13                      8.51
  ZDBp898   DM0      6.14               2.77                      9.73
  ZDBp901   DM0      3.91               1.83                      5.64
  ZDBp904   DM0      3.84               1.78                      5.68
  ZDBp910   DM25     4.71               2.40                      6.47
  ZDBp911   DM25     3.13               1.58                      5.01
  ZDBp912   DM25     8.93               4.51                      13.41
  ZDBp913   DM25     4.83               2.68                      6.94
  ZDBp914   DM25     4.11               2.03                      6.17
  ZDBp915   DM25     3.31               1.78                      5.19
  ZDBp916   DM25     4.87               2.67                      6.95
  ZDBp917   DM25     3.20               1.77                      4.63
  ZDBp918   DM25     3.66               1.88                      5.18
  ZDBp919   DM25     2.91               2.06                      3.81
  ZDBp920   DM25     3.92               2.08                      5.49
  ZDBp921   DM25     5.76               2.93                      9.15

[^\*^]{.smallcaps}These bounds indicate the ratio of the minimum and maximum sequencing coverage measured at the *citT* locus to the mean coverage over the genome. In all cases, the estimated copy number is significantly greater than one at p\<0.0001, even after Bonferroni corrections for multiple tests of the same hypothesis.

###### Copy number of amplified *maeA* and *dctA* genes in sequenced clones from populations that evolved for 2500 generations in either DM0 or DM25 environments.

Table 2---source data 1.Copy number of amplifications affecting *citT, dctA, and maeA* in the ancestral and evolved clones.

  Genome    Medium   Gene        Mean copy number   Minimum number^\*^   Maximum number^\*^   Adjusted *p*-value^†^
  --------- -------- ----------- ------------------ -------------------- -------------------- -----------------------
  ZDBp880   DM0      *dctA*      2.33               1.67                 3.26                 \<0.0001
  ZDBp886   DM0      *dctA*      3.20               1.88                 4.25                 \<0.0001
  ZDBp898   DM0      *dctA^‡^*   2.09               1.71                 2.76                 0.0023
  ZDBp913   DM25     *dctA*      3.17               1.91                 4.68                 \<0.0001
  ZDBp918   DM25     *dctA*      3.41               1.80                 5.19                 \<0.0001
  ZDBp919   DM25     *dctA*      2.60               2.06                 3.29                 \<0.0001
  ZDBp883   DM0      *maeA*      58.47              22.61                95.46                \<0.0001
  ZDBp889   DM0      *maeA*      34.71              2.35                 55.39                \<0.0001
  ZDBp904   DM0      *maeA*      28.08              15.30                44.72                \<0.0001
  ZDBp911   DM25     *maeA*      2.22               1.54                 3.39                 \<0.0001
  ZDBp917   DM25     *maeA*      4.72               3.56                 6.18                 \<0.0001
  ZDBp919   DM25     *maeA*      12.81              2.16                 18.00                \<0.0001

^\*^These bounds indicate the ratio of the minimum and maximum sequencing coverage measured at the indicated locus to the mean sequencing coverage over the genome.

^†^Significance levels are shown after Bonferroni corrections for multiple tests of the same hypothesis.

^‡^There may be two discontinuous amplifications of *dctA* in this genome, or there may be a single continuous amplification with a short region of low coverage within the gene. The second region of amplification has a similar copy number. We present data for only one region, which provides a conservative estimate of the overall statistical significance in this case.

![Genetic amplifications in evolved clones.\
Genomic regions with significant amplifications in DM0- and DM25-evolved clones, arranged by chromosomal position. The evolved clones from DM0 (top half) and DM25 (bottom half) are indicated at the near left, with the total amplified length shown at the far left. Dashed vertical lines mark the *maeA* and *dctA* loci. The boundaries vary among the subset of genomes with amplifications that encompass these genes; by contrast, the *citT* locus is amplified in all of these genomes, and with nearly uniform boundaries. Colors denote amplification copy-number on a log~2~ scale from dark (low copy-number) to light (high copy-number).\
Figure 13---source data 1.Table of amplifications discovered by examining sequencing coverage in evolved genomes.](elife-55414-fig13){#fig13}

Other amplifications include the *dctA* gene ([Table 2](#table2){ref-type="table"}). DctA is a proton motive force-driven, generalized di- and tricarboxylic acid transporter. During growth on citrate, the CitT antiporter protein exports TCA cycle intermediates into the medium in exchange for citrate. DctA enables recovery of those intermediates. Two mechanisms of increasing *dctA* expression have been shown to improve growth on citrate. [@bib70] identified mutations in the *dctA* promoter that cause high-level expression. [@bib87] showed that increased copy number of *dctA* is likewise beneficial. We found evidence that these two mechanisms are anticorrelated. Two of the ancestral clones, CZB151 and CZB154, have a shared (identical by descent) mutation in the promoter sequence of *dctA*. The third ancestor, CZB152, lacks this mutation. Only one of the 16 evolved descendants of CZB151 or CZB154 has a *dctA* amplification, whereas five of CZB152's eight descendants have such an amplification (Fisher's exact test: p=0.0069). Also supporting this anticorrelation, one of the three CZB152 descendants without a *dctA* amplification independently evolved a mutation affecting that gene's promoter.

We identified another set of parallel amplifications in six evolved genomes. These amplifications are large and highly variable in extent, but all include at least the *fdnI*, *yddM*, *adhP, maeA, rpsV,* and *bdm* genes. These amplifications were often present in high copy numbers. Three DM25-evolved genomes have 2--13 copies, and three that evolved in DM0 have 28--59 copies ([Table 2](#table2){ref-type="table"}). In one case, ZDBp889, the amount of DNA in the amplified region constitutes more than 15% of the total evolved genome ([Figure 13](#fig13){ref-type="fig"}). By contrast, the amplifications of *citT* and *dctA* contain an average of 4--5 and 2--3 copies, respectively ([Tables 1](#table1){ref-type="table"} and [2](#table2){ref-type="table"}).

These long, high-copy-number amplifications must exert a metabolic burden, due to the costs of additional DNA synthesis and increased gene expression ([@bib17]; [@bib46]). The repeated evolution of amplifications of this genomic region suggests that they confer some selective benefit that outweighs their cost. We examined the genes shared among the amplifications to identify which might confer this benefit. The *rpsV* gene, which encodes the 30S ribosomal subunit protein D, appears to have been a minor target for adaptation to DM0 based on parallel mutations ([Figure 11](#fig11){ref-type="fig"}). The *maeA* gene encodes an NAD^+^-dependent oxaloacetate-decarboxylating malate dehydrogenase (EC 1.1.1.38) that catalyzes the decarboxylation of malate to pyruvate. This plausible connection to citrate metabolism led us to hypothesize that increased *maeA* dosage and expression provides the benefit that overcomes the cost imposed by the amplifications.

Increased MaeA expression is highly beneficial in the citrate-only environment {#s2-9}
------------------------------------------------------------------------------

We tested our hypothesis that increased *maeA* dosage confers a fitness benefit by transforming the ancestral strains CZB151 and CZB152 with a low-copy plasmid, RM4.6.2, which contains a copy of *maeA* that is under the control of a strong constitutive synthetic promoter and ribosome-binding site. These Ara^−^ RM4.6.2 transformants were competed in DM0 against Ara^+^ mutants (ZDB67 and ZDB68, respectively) of the same clones transformed with the empty-plasmid control. The RM4.6.2 transformants had a fitness advantage of \~28% in both the CZB151 (*n* = 6; mean fitness = 1.2790, *t*-distributed 95% confidence interval: \[1.2636, 1.2944\]) and CZB152 (*n* = 6; mean fitness = 1.2778, *t*-distributed 95% confidence interval: \[1.2597, 1.2959\]) backgrounds relative to their otherwise isogenic competitors. Overexpression of *maeA* is therefore highly beneficial in the DM0 environment, and its benefit likely explains the high-copy-number amplifications containing *maeA* found in many evolved clones.

We used RNA-Seq to verify that clones with *maeA*-containing amplifications have elevated transcription of that gene. We compared the transcriptomes of two ancestral clones (CZB151 and CZB152) and two DM0-evolved clones with *maeA* amplifications (ZDBp883, ZDBp889). Both evolved clones do, indeed, have much higher levels of *maeA* expression than their respective ancestors ([Figure 14](#fig14){ref-type="fig"}).

![Transcriptomic analysis of ancestral and evolved clones.\
Differential expression analysis comparing two ancestral (CZB151 and CZB152) and three evolved clones (ZDBp877, ZDBp883, ZDBp889), produced by *sleuth* ([@bib65]). The colored bar (at right) shows the level of RNA expression based on estimated counts and transformed as log~2~(1 + est_counts). The differentially expressed genes discussed in the main text are shown here. The numeric labels after the strain identifiers indicate the two or four biological replicates for each clone (i.e., RNA samples prepared from independently revived cultures of that clone).\
Figure 14---source data 1.RNA transcript quantification using *kallisto* software.](elife-55414-fig14){#fig14}

Despite the large fitness advantage conferred by increased *maeA* dosage in the citrate-only DM0 environment, most of the evolved Cit^+^ genomes we examined do not have *maeA* amplifications. Moreover, although three of the DM25-evolved genomes in this study have large *maeA* amplifications ([Table 2](#table2){ref-type="table"}), none have been found in the sequenced genomes of Cit^+^ clones isolated from the Ara−3 parent population in the LTEE itself. This discrepancy might be explained by the evolution of increased *maeA* expression via other mutations. To evaluate this possibility, we also used RNA-Seq to examine the transcriptome of ZDBp877, a DM0-evolved clone without a *maeA* amplification. In contrast to ZDBp883 and ZDBp889, ZDBp877 expresses *maeA* at a level similar to that of the ancestral clones ([Figure 14](#fig14){ref-type="fig"}). This finding means that at least some, and perhaps all, of the evolved clones without *maeA* amplifications lack mutations that boost its expression.

Transcriptomic analysis of DM0-evolved clones {#s2-10}
---------------------------------------------

We identified other potentially adaptive differences in transcription between the DM0-evolved clones during growth in the DM0 medium ([Figure 14](#fig14){ref-type="fig"}). The two evolved clones with *maeA* amplifications, ZDBp883 and ZDBp889, both show increased expression of the *fad* fatty acid β-oxidation regulon, whereas ZDBp877, which lacks a *maeA* amplification, does not. ZDBp877 and ZDBp889, but not ZDBp883, both downregulate the cytochrome *bo~3~* terminal oxidase complex, *cyoABCD*. We also found three genes with more extreme differential expression than *maeA* between the clones with and without the *maeA* amplification. These genes are *dinI, gltS, and ECB_03510*, all three of which are strongly downregulated in ZDBp877 in comparison to both clones with the amplification. DinI is a DNA-damage inducible protein that regulates the SOS response. GltS is a glutamate/sodium symporter, while *ECB_03510* encodes a protein of unknown function that lies immediately downstream of *gltS*.

These differences aside, we found largely similar changes in gene expression across the three DM0-evolved clones relative to their ancestors ([Figure 14](#fig14){ref-type="fig"}). All three display strong downregulation of the UspB stress protein encoded by *yhiO*, presumably caused by the parallel IS*150* insertions into that gene's promoter. We also found extensive downregulation of genes encoding ribosomal proteins (including *rpsB*, *rpsU*, *rpsO*, *rpsT, rplE, rplJ*, *rplN*, and *rplX*); genes involved in RNA transcription (*rpoA, rpoB, rpoC, rpoS*, *rho*); and DNA-replication associated genes (*gyrA*). Other down-regulated genes in the evolved clones include the *nuo* operon, which encodes NADH dehydrogenase in the respiratory electron transport chain, and key TCA cycle genes including those encoding the 2-oxoglutarate dehydrogenase complex (*sucB*, *sucC*, and *lpdA*). By contrast, we see strong upregulation of genes encoding certain prophage-associated proteins (ECB_00826 and ECB_00827); some toxin-antitoxin pairs (*chpA-chpR*); proteins involved in recombinational DNA repair (*recA* and *recN*); SOS response proteins (*dinD*, *sulA*, *umuC*, and *umuD*); proteins associated with stationary phase (*csiE* and *sbmC*); a biofilm-associated stress protein (*bhsA*); and others of unknown significance ([Supplementary file 3](#supp3){ref-type="supplementary-material"}).

The downregulation of transcription, translation, and NADH dehydrogenase genes and the increased expression of stress-associated genes suggest that adaptation to DM0 involved reducing growth rate (relative to the faster growth on glucose), presumably to achieve balanced growth on citrate alone. The upregulation of fatty-acid β-oxidation genes (albeit less so in the ZDBp877 clone without the *maeA* amplification) also indicates some remodeling of the connection between fatty acid and citrate metabolism that is mediated by acetyl-CoA. Other changes, including the upregulation of the *fad* operon encoding fatty acid degradation in ZDBp883 and ZDBp889, the anaerobic glycerol-3-phosphate dehydrogenase operon (*glpABCD*) in ZDBp877 and ZDBp889, and the glycerol-3-phosphate transporter (*glpD* and *glpT*) in ZDBp883 ([Supplementary file 3](#supp3){ref-type="supplementary-material"}), suggest adaptation to scavenging on dead and dying cells in the DM0 populations.

Discussion {#s3}
==========

It is rarely feasible to examine evolution in action as organisms invade, colonize, and adapt to a new niche in nature, especially with independently evolving replicates and control populations. In this study, we investigated how *E. coli* variants with the new ability to grow aerobically on citrate adapted to a novel, citrate-only resource environment in the laboratory. We examined the genomic and phenotypic evolution of 12 initially clonal populations after 2500 generations in this new environment, along with 12 initially identical control populations maintained for the same time in the ancestral environment that contains glucose as well as citrate, to better understand their post-invasion potential, including refinement of the Cit^+^ trait.

The founding clones grew poorly in their new medium, exhibiting long lag phases, slow growth, and high variation in their growth kinetics. However, those founding clones had substantial potential to adapt to citrate as their sole carbon and energy source, as the experimental populations evolved shorter lag times and faster growth rates in DM0. The evolved populations also showed correlated improvements in the ancestral glucose-citrate medium, DM25. These changes are consistent with selection pressures typical for evolution experiments that use a serial batch-culture regime like that of the LTEE ([@bib89]), upon which our experiment was based. In contrast to the LTEE, but consistent with other lines of evidence that growth on citrate is stressful for *E. coli*, the growth-curve trajectories and even stationary-phase optical densities exhibited substantial variability for replicate assays performed using the same population sample. Assays of competitive fitness over the same 24 hr transfer cycle also showed extreme variability, especially in DM0, making it difficult to reliably estimate overall fitness gains. Increasing the duration and replication of the fitness assays should help reduce this variation in future work. Nonetheless, our difficulty in measuring adaptation in this system is striking in contrast to the ease of doing so in the LTEE ([@bib42]; [@bib91]). It is also possible that other demographic components of fitness besides shorter lag times and faster growth rates are at play in this citrate-based system. Indeed, we observed extensive cell death in Cit^+^ clones, and the level of mortality varied considerably even between replicate assays for reasons that we do not understand.

The evolved clones exhibit even greater variation in their growth phenotypes. While most have faster growth rates and shorter lag times, similar to the improvements observed at the population level, some evolved clones grow only slightly better, or even worse, than their ancestors. Similarly, most evolved clones show no significant increase in fitness, and some are less fit than their ancestor, even in the environment where they evolved. In some cases, the fitness estimates are discordant with measured growth characteristics. For example, one clone from a population that evolved in DM25 (ZDBp917) has a lag time far longer than its ancestor, yet it has a marginally higher fitness.

Complex ecological interactions between genotypes might explain such discordant outcomes between competitive fitness assays and growth parameters estimated in pure culture. For example, non-transitive competitive interactions can give rise to evolved clones that are more fit than their immediate predecessors, but less fit than their earlier ancestors ([@bib62]; [@bib14]). We cannot exclude the possibility of non-transitive dynamics in our system at this time, but we note that they have not been observed in the LTEE on which our experiments are based ([@bib20]; [@bib45]). A more likely alternative is that the paradoxical changes in fitness and growth are caused, in part, by cross-feeding and similar negative frequency-dependent interactions. The ancestral clones, for example, might be better at invading some of the evolved communities than they are at growing alone in the same medium. Similarly, some evolved clones with paradoxical growth phenotypes might be specialized ecotypes that have adapted to unknown niches, such as scavenging on dead cells or cross-feeding on metabolites produced by coexisting lineages ([@bib84]; [@bib74]; [@bib90]; [@bib41]; [@bib51]; [@bib30]). We will investigate the possibility of complex ecological interactions in future work.

Genomic plasticity reflecting copy-number variation and transposable-element activity played a key role in adaptation to the citrate niche. These findings support and extend previous work showing the importance of such plasticity in adaptation to other selective challenges ([@bib16]; [@bib88]; [@bib68]; [@bib40]), including the rapid evolution of antibiotic heteroresistance in some pathogens ([@bib59]). Our work especially bolsters previous demonstrations of the evolutionary importance of dynamic gene amplifications, which increase the dosage of genes encoding specific products needed at higher levels ([@bib63]; [@bib2]). For example, [@bib6] found that *E. coli* strains with single-gene knockouts rapidly re-evolved the capacity to grow in minimal medium in part via amplifications that increased genome size by more than 20%. Such amplifications may also impose substantial metabolic costs, and they are prone to recombination-mediated collapse, so they are readily lost when the relevant gene products are no longer needed at higher levels. Amplifications also increase the opportunity for further mutations that may provide a benefit for a single copy, thereby favoring subsequent collapse and elimination of the cost of multiple copies ([@bib2]; [@bib13]; [@bib58]). In addition to their role as substrates for promoting amplifications, IS elements seem to have both inactivated and modulated the expression of various genes in our evolution experiment. The activity of some IS elements appears to be increased by stress, which cells may experience when they invade a new niche to which they are poorly adapted ([@bib88]). Of course, this plasticity is a double-edged sword: the genomic instability that transposable elements cause can also produce deleterious mutations, which could impede adaptation and might even lead to extinction, especially when small founding populations invade a new niche.

Altogether, our results have several nuanced implications for evolution following the innovation-driven discovery of new niches. They suggest that genomes often possess latent potential to refine novel traits and adapt to new niches. This potential can be fulfilled not only by point mutations, but also via larger mutations such as gene amplifications and transpositions that may allow more rapid adaptation after niche discovery. Despite such adaptation, however, suboptimal traits may persist long after the new niche has been successfully invaded. In our study, the evolved Cit^+^ bacteria's physiology shows an evolutionary mismatch with their growth on the newly accessible citrate, even after thousands of generations of adaptation to that new niche. Evidence for the mismatch includes erratic growth trajectories and fitness measures that suggest extreme sensitivity to small differences in the environment, the identity of competitors, or both. It is also seen in the high levels of mortality during stationary phase in some Cit^+^ clones, as shown using live-dead staining of cells. Further evidence comes from analyses of transcriptomic data, which shows that some Cit^+^ lines evolved increased expression of stress-associated genes during exponential phase. Thus, while a nascent ecotype's latent potential for adaptation may allow its establishment in a new niche (especially in the absence of established competitors), it may nonetheless continue to experience stress and suffer from suboptimal phenotypes for a long time before becoming truly well suited to its new conditions.

Our findings also highlight that the fact that organisms are historically contingent patchworks of traits and functions constructed by evolutionary tinkering, and so they are rife with design compromises ([@bib66]; [@bib82]; [@bib33]). Natural selection integrates these complex assemblies into idiosyncratic, but usually robust and stable, biological systems. This stability can be disrupted, however, such as when a novel trait that is beneficial, on the whole, nonetheless generates new stresses. These secondary tradeoffs are also implicit in Fisher's geometric model of adaptation, in which mutations of large effect, including those that produce new functions, are especially likely to disrupt other phenotypes ([@bib27]; [@bib60]). We have shown that such disruptions can persist for thousands of generations, which implies that re-evolving a stable, robust system in which a novel trait is fully integrated with the preexisting physiology can be difficult.

Organisms typically maintain their physiological systems at a dynamic steady state. This homeostasis implies that organisms have evolved to maintain physiological variables within an acceptable range in the face of perturbations ([@bib1]). Failure to maintain homeostasis may result in illness and even death. Viability is sometimes possible outside the usual range of homeostasis, but often at the cost of stress and lasting damage to the organism. Our findings imply that the disruptions caused by evolutionary novelties can maladaptively change the system parameters that maintain homeostasis, thereby causing stress and increasing mortality. Many questions remain about the nature and consequences of these homeostatic disruptions, as well as how novel traits might eventually become well integrated with an organism's existing physiology to restore its prior homeostasis.

Our experimental system has the potential to address these and other questions about innovation, adaptation, and maladaptation that are relevant to both evolutionary biology, in general, and evolutionary medicine, in particular. In humans, for example, cultural innovations, including the agricultural revolution, have vastly reshaped our diets and thereby also changed our gut microbiota ([@bib57]; [@bib18]). Contemporary high-calorie diets and sedentary lifestyles have led to an epidemic of associated illnesses, including hypertension, diabetes, and obesity. Might new traits typically exhibit more phenotypic variation, reflecting greater sensitivity to intrinsic stochasticity, lower robustness to environmental perturbations, or both? If growth on citrate by *E. coli* required major changes in physiology and metabolism, then that innovation may have increased fragility due to new difficulties in coordinating cell growth and division ([@bib77]; [@bib75]). By disrupting existing physiological and metabolic processes, innovations can introduce new compromises and imbalances, the resolution of which requires novel variation. That new variation may, in turn, affect correlated traits and the organism's overall robustness. We conjecture that the evolutionary refinement of traits that open new niches may often promote evolvability at the expense of robustness and overall good health ([@bib44]).

Materials and methods {#s4}
=====================

Key resources are listed and described in [Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table.

Evolution experiment {#s4-1}
--------------------

We previously isolated three random Cit^+^ clones, designated as CZB151, CZB152, and CZB154, from the 33,000-generation sample of LTEE population Ara−3 ([@bib7]). We also isolated spontaneous Ara^+^ revertants for each clone, designated as ZDB67, ZDB68, and ZDB69, respectively. For long-term preservation, we inoculated Luria Bertani (LB) broth with isolated colonies of each clone and its revertant, grew them overnight at 37°C with orbital shaking at 120 rpm, and froze samples of each at −80°C with glycerol as cryoprotectant. We revived the clones and revertants from the frozen stocks and grew them in LB overnight. We then diluted the LB cultures 10,000-fold into 9.9 mL of Davis Mingioli (DM) minimal medium supplemented with 25 mg/L glucose (DM25), and grew them at 37°C with orbital shaking at 120 rpm. After 24 hr, we diluted these cultures 100-fold in 9.9 mL of fresh DM25 and grew them for another 24 hr. This preconditioning acclimated the bacteria to growing on citrate. The preconditioned cultures were then diluted 100-fold into 9.9 mL of base DM medium (DM0), which lacks any glucose but contains 1 g/L (1,700 mM) of citrate for carbon and energy. We started two replicate populations from each LTEE-derived clone and each revertant, for a total of 12 DM0 populations. At the same time, we inoculated 12 populations into DM25 ([Figure 1](#fig1){ref-type="fig"}). We maintained these DM25 populations at 37°C with orbital shaking, and transferred them by 100-fold dilution into fresh DM25 every 24 hr (i.e., the same conditions as in the LTEE) for 375 transfers and 2500 generations in total. The founding Cit^+^ clones grow poorly in the citrate-only resource environment. They were unable to reach stationary phase or, in some cases, exponential phase within 24 or even 48 hr. We therefore incubated the DM0 populations for 72 hr after their initial inoculation so they could reach stationary phase before transfer to fresh medium. We then diluted them 100-fold into 9.9 mL of DM0 every 48 hr for seven cycles (two weeks), and then subsequently every 24 hr for a total of 375 transfers and 2500 generations. Every 37 days (\~250 generations) samples of each population were frozen with glycerol at −80°C.

Isolation of evolved clones {#s4-2}
---------------------------

We revived each evolved population sample by inoculating 100 μL of the stock frozen at generation 2500 into 9.9 mL of LB broth and incubating overnight at 37°C with orbital shaking. We then diluted the revived DM0- and DM25-evolved populations 10,000-fold in 9.9 mL of DM0 or DM25, respectively, and grew them for 24 hr at 37°C with orbital shaking, followed by 100-fold dilution into fresh DM0 or DM25 and another 24 hr period of growth at 37°C with orbital shaking. We then diluted each population 100,000-fold in 0.85% saline and spread 100 μL on an LB agar plate marked with three dots on the bottom. We streaked the colony closest to each dot on an LB plate after 48 hr of incubation at 37°C, thereby providing three randomly chosen clones from each population. We then inoculated an isolated colony of each clone into LB broth, grew it overnight, and froze it as before.

Fitness assays {#s4-3}
--------------

We measured fitness by performing competition experiments modified from those described by [@bib42]. We revived samples by inoculating 15 μL (for clones) or 100 μL (for whole populations) from a slightly thawed frozen stock into 10 mL of LB. These cultures then grew overnight at 37°C with 120 rpm orbital shaking, after which we diluted each 10,000-fold into either DM25 or DM0 and preconditioned as described above. We inoculated 50 μL of each competitor's preconditioned culture into 9.9 mL of the corresponding medium, vortexed to mix, and then we spread 100 μL of 10^−2^ and 10^−3^ dilutions on Tetrazolium Arabinose (TA) indicator agar plates to estimate the competitors' initial densities. We estimated their densities again at the end of the assay by spreading 100 μL of 10^−4^ and 10^−5^ dilutions on TA plates. For whole populations, we assayed fitness with 3-fold replication in one-day competitions, in which final densities were estimated after 24 hr. For the evolved clones, we assayed fitness with 5-fold replication, and measured final densities after 3 days, with 100-fold serial transfers to fresh medium after 24 and 48 hr. The realized growth rates of the two competitors were determined from their starting and ending densities, accounting for the dilutions. We calculated the fitness of an evolved clone or population as its realized growth rate divided by that of the ancestral competitor. In the population fitness assays, ZDB67 was the common competitor for all Ara^−^ population samples, and CZB151 was the common competitor for all Ara^+^ population samples.

Growth curves {#s4-4}
-------------

We chose one of the three evolved clones from generation 2500 from each DM0 or DM25 population, then revived and preconditioned it in DM0 or DM25 as described above. We diluted the cultures 100-fold into 9.9 mL of DM0 or DM25, vortexed, and dispensed six 200 μL aliquots of each culture into wells in a 96-well plate. We randomized well assignments for the cultures to minimize position effects. We measured optical density (OD) at 420 nm wavelength every 10 min for 48 hr using a Molecular Devices SpectraMax 384 automated plate reader. We discarded the measurements taken before 30 min from our analysis.

Microscopy and cell viability analyses {#s4-5}
--------------------------------------

We performed microscopy and viability analyses on cells derived from five clones: the LTEE ancestor (REL606); one of the three Cit^+^ ancestors in our evolution experiment (CZB151); two of its descendants that evolved in DM0 and DM25 for 2500 generations (ZDBp871 and ZDBp910, respectively); and a Cit^+^ clone isolated at generation 50,000 of the LTEE (REL11364). We revived clones from the frozen stocks and preconditioned them as described above, except that the preconditioning steps in DM0 or DM25 were extended to four daily passages to ensure acclimation to these environments. We performed preparations for live/dead cell staining and microscopic analyses on the fifth day. In these preparations, we concentrated the cells in each culture by centrifugation at 7,745 g for 8 min and decanted the supernatant. We then resuspended the cell pellets in Corning tubes containing 10 mL of 0.85% saline, and incubated them at room temperature for 1 hr; we inverted the tubes every 15 min. We then centrifuged these cultures for an additional 8 min, decanted the supernatant, and resuspended the cell pellets in 0.85% saline. We adjusted the volume of saline based on variation in turbidity to ensure that we had sufficient cells in a typical field of view for microscopy. We examined 14--55 fields per replicate for each combination of strain and media treatment. Total cell counts ranged from approximately 15,000 to 60,000 for the various combinations of clones and culture media.

We used the LIVE/DEAD *Bac*Light Viability Kit for microscopy (ThermoFisher \#L7007), following the manufacturer's directions for fluorescently labeling cells. In short, we mixed components A and B in equal amounts, added 1 µl to each culture containing resuspended cells, and incubated them for 20 min in the dark to prevent photobleaching. After labeling, we fixed 3 µL of each sample onto a 1% agarose pad and performed fluorescent microscopy using a Nikon Eclipse Ti inverted microscope. Phase-contrast images were taken using diascopic illumination with an exposure time of 100 ms. Fluorescence was measured with an exposure time of 200 ms at 25% power of the fluorescent light source using two filter sets, 49003-ET-EYFP and 49008-ET-mCherry Texas Red (Chroma), which correspond to the fluorescence spectra of 'live' and 'dead' cells, respectively. All images were taken at 100× magnification.

We analyzed micrographs using *SuperSegger*, an image-processing package ([@bib79]). We first filtered the data, keeping only those values for segmented regions in the micrograph that were scored by the neural-network classifier as having *P*(Cell = True) \> 75%. (Region scores range between −50 and 50, so we used data only from regions with values between 25 and 50). We then used the fluorescence values from the *SuperSegger* output and scored individual cells as 'live' or 'dead' depending on whether the fluorescence signal on the green (YFP) channel was greater or lesser, respectively, than the signal on the red (RFP) channel. We calculated the proportion of dead cells across the many fields examined for each of the five replicate cultures that we analyzed for each combination of clone and growth medium, and we used these values in the statistical analyses.

Genomic analysis and copy-number variation {#s4-6}
------------------------------------------

We thawed the 3 Cit^+^ founder strains (CZB151, CZB152, CZB154), their respective Ara^−^ derivatives (ZDB67, ZDB68, ZDB69), and 25 evolved clones (one Cit^+^ clone from each DM0 and DM25 evolved population, plus the anomalous Cit^−^ clone ZDBp874) and grew them overnight in LB broth. We isolated genomic DNA from each sample using the Qiagen Genomic-tip 100/G DNA extraction kit. The genomic DNA was then sequenced using the platforms in the core facilities shown in [Supplementary file 4](#supp4){ref-type="supplementary-material"}.

For genomes sequenced at UT Austin, we purified DNA from *E. coli* cultures using the PureLink Genomic DNA Mini Kit (Invitrogen). For each sample, we fragmented 1 µg of purified DNA using dsDNA Fragmentase (New England Biolabs). We then used the KAPA Low Throughput Library Preparation kit (Roche) to construct Illumina sequencing libraries according to the manufacturer\'s instructions with two exceptions. First, we reduced reaction volumes by half. Second, we designed DNA adapters that incorporate additional 6-base sample-specific barcodes such that the barcodes are sequenced as the first bases of both read 1 and read 2. We performed paired-end sequencing with 300-base reads on an Illumina MiSeq at the University of Texas at Austin Genome Sequencing and Analysis Facility. Reads were demultiplexed using a custom python script. We trimmed barcodes and adapter sequences using *Trimmomatic* version 0.38 ([@bib11]).

When available, we combined short-read data from different platforms before mutation identification. We identified mutations using *breseq* version 0.33.2 ([@bib22]). We used a bash script called 'generate-LCA.sh' to infer the last common ancestor (LCA) of all evolved strains by taking the intersection of mutations found in previously curated genomes for CZB152 and CZB154; those curated founder genomes (and others) are available at: <https://github.com/barricklab/LTEE-Ecoli> ([@bib3]). We further analyzed the mutations called by *breseq* relative to the LCA using custom python and R scripts available and described at: <https://github.com/rohanmaddamsetti/DM0-evolution> ([@bib53]).

We used the following algorithm to find copy-number variation in the genomes. The *breseq* pipeline models 1× copy number using a negative binomial distribution fit to coverage, truncating high and low coverage that might be caused by amplifications and deletions, respectively. We then identified all positions in the genome that rejected that negative binomial at an uncorrected *p* = 0.05. Finally, we calculated a Bonferroni-corrected *p*-value for contiguous stretches of the genome in which the 1× null model was rejected at each site. We examined coverage at sites separated by the maximum read length to ensure they were not spanned by a single read. For example, in the case of a region of elevated coverage that was 1000 bp in length, covered by 150-base Illumina sequencing reads, the value of *P*(*coverage* = *min*)^6^ would be calculated, where *min* is the minimum coverage in that region, *P*(*coverage* = *min*) is the probability of that minimum coverage under the negative binomial null model, and six represents the (integer) number of sites that are 150 bp apart in the 1000 bp stretch. The output was then filtered for regions longer than 2 × 150 = 300 bp to remove potential false positives. The Bonferroni calculation included corrections for checking every site in the genome in addition to the number of sites that passed the initial 0.05 cutoff for deviations from the negative binomial expectation. All gene amplifications detected in the DM0- and DM25-evolved genomes are reported in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Statistical test for selection on parallel IS*150* insertions {#s4-7}
-------------------------------------------------------------

To test for positive selection on parallel IS*150* insertions, we simulated a null model of insertion-site preferences based on the observed data. We conservatively assumed that IS*150* elements can only insert into the positions where we observed insertions in one or more sequenced genomes from either this experiment or the LTEE ([@bib80]). We also assumed that the probability of IS*150* transposing into a given site is proportional to the observed number of IS*150* insertions at that site across the sequenced genomes, as would be the case if mutational biases alone accounted for the parallel IS*150* insertions. We then used the non-parametric bootstrap method (100,000 replicates) to calculate the probability that any particular site would be hit by so many IS*150* elements among the DM0-evolved genomes, holding the number of IS insertions over that group fixed.

RNA-Seq and transcriptome analysis {#s4-8}
----------------------------------

We performed RNA-Seq on six clones: the three Cit^+^ clones from the LTEE used as ancestors in our evolution experiment (CZB151, CZB152, and CZB154) and three evolved descendants isolated after 2500 generations of adaptation to DM0 (ZDBp877, ZDBp883, and ZDBp889). We revived each clone from a frozen stock in LB as described above. For preconditioning to minimal medium, we diluted each culture 10,000-fold into DM25 with four-fold replication and allowed them to grow for 24 hr at 37°C with 120 rpm orbital shaking. We then diluted the 16 resulting cultures 100-fold in DM0 and grew them for 48 hr at 37°C with shaking, for preconditioning to the citrate-only medium. We diluted the mature cultures 100-fold again into fresh DM0, and grew them to OD~600 ~0.2 -- 0.3, corresponding to mid-log phase, at which point we extracted their RNA using the cold phenol-ethanol method ([@bib5]). We recovered RNA using a Qiagen RNeasy MiniKit (\#74104), and removed DNA with a Qiagen RNase-free DNase set (\#79254). RNA was diluted to 50 ng/mL with nuclease-free water and cDNA amplified by RT-PCR. Purified cDNA was then sequenced by Admera Health (South Plainfield, NJ). We used *kallisto* version 0.44 ([@bib12]) to quantify RNA transcripts and *sleuth* ([@bib65]) to conduct differential-expression analysis and visualization. These results are presented in [Supplementary file 3](#supp3){ref-type="supplementary-material"}.

Construction of *maeA* plasmid {#s4-9}
------------------------------

We constructed a medium-copy-number plasmid based on the kanamycin resistance cassette-containing plasmid, pSB3K3, in which the *maeA* gene was placed under the control of a strong constitutive synthetic promoter and ribosome binding site, P089-R052, described by [@bib39]. We used PCR to amplify the *maeA* gene from REL606 and the pSB3K3 plasmid. We ordered the P089-R052 promoter as an oligonucleotide. We assembled these components using circular polymerase cloning ([@bib69]) and Gibson assembly ([@bib29]). We performed drop dialysis using Millipore membrane filters (VSWP01300) for 15 min to desalt the assembly reactions before electroporation. We isolated transformants on LB-Kanamycin plates and used PCR to find colonies that contained the P089-R052--*maeA* insert. We used Sanger-sequencing of plasmid inserts to verify that no unintended point mutations had occurred during construction. We designated the final plasmid containing the P089-R052-*maeA* insert in the pSB3K3 backbone RM4.6.2.

Competition experiments to assess fitness effects of *maeA* {#s4-10}
-----------------------------------------------------------

We transformed the Cit^+^ ancestral clones CZB151 and CZB152 and their Ara^+^ revertants, ZDB67 and ZDB68, respectively, with the plasmid RM4.6.2. We also transformed the same clones with the empty pSB3K3 vector. We froze stock cultures of each transformant at −80°C with glycerol as a cryoprotectant.

We competed each RM4.6.2 transformant against its cognate pSB3K3 transformant in the clone with the opposite Ara marker state. Briefly, we revived all eight transformants in LB supplemented with 50 μg/mL kanamycin and grew them overnight at 37°C with 120 rpm orbital shaking. We then diluted each overnight culture 10,000-fold in 9.9 mL DM0 and incubated for 48 hr at 37°C with orbital shaking, after which they were diluted 100-fold in fresh DM0 every 48 hr three times to acclimate cells to the citrate-only resource environment. We commenced the competition assays the next day by inoculating 9.9 mL DM0 with 50 μL each of an RM4.6.2 transformant and the oppositely marked pSB3K3 transformant, with fourfold replication for a total of 16 competitions. We ran three-day competitions to estimate fitness as described above.

Data availability statement {#s4-11}
---------------------------

All analysis and statistical scripts have been deposited at [www.datadryad.org](http://www.datadryad.org) (<https://doi.org/10.5061/dryad.7wm37pvpp>). RNA-Seq data have been deposited in the NCBI SRA under accession PRJNA553503. Genome sequencing data have been deposited in the NCBI SRA under accession PRJNA595472. Analysis code is also available at: <https://github.com/rohanmaddamsetti/DM0-evolution> ([@bib53]; copy archived at <https://github.com/elifesciences-publications/DM0-evolution>).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Understanding the evolutionary challenges faced by organisms as they respond to new environmental conditions is a significant, but often intractable problem. The discovery of *Escherichia coli* lineages from long-term experimental evolution populations that evolved ability to metabolise citrate under aerobic conditions has provided a window to deeper understanding. Of particular note are dynamic mutational processes underpinned by amplifications and insertion sequence movement, and the curious, but entirely believable finding, that adaptation to the new citrate environment is limited by physiological constraints.

**Decision letter after peer review:**

Thank you for submitting your article \"Genomic and phenotypic evolution of *Escherichia coli* in a novel citrate-only resource environment\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Patricia Wittkopp as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

All reviewers and editors find the work a useful extension of the cit^+^ (invasion of new niche) angle arising from the LTEE and appreciate the new insights particularly concerning structural variant mutations. The work should be broadly valued by the field and especially understanding of how capacity to utilise citrate has become refined during the course of the selection experiment.

Summary:

Blount et al. founded 24 experimental populations from cit^+^ clones, 12 replicates were evolved in DM25, and 12 in DM0. At the end of the evolution experiment the authors characterised growth phenotypes, sequenced clones and followed up with some plasmid complementation and gene expression analysis. The systematic and thorough follow up on the evolved clone from DM0-2, ZDBp874 is a good example of the elegant experimental design and clear writing that characterise this study- it is very easy to follow. Overall, the genetic characterisation of the populations is thorough, although this part would have benefited from temporal analysis of mutations. Arguably the most interesting part of the work arises from phenotypic analysis of derived lines, but here we have concerns regarding the conclusions.

Major concerns:

All reviewers were surprised to find that derived lines were not subject to standard population-level assays of competitive fitness. Instead, OD was used as a phenotypic measure of performance, sometimes with populations, but the more significant data came from analysis of individual clones. Reliance on OD, without calibration against viable cell counts, can result in misleading conclusions. Small differences in death, or cell size, all impact on OD. In a similar vein, Figure 6---figure supplement 1: Some populations (both ancestors and evolved strains) appear to reach a much higher OD. This receives no comment but it would appear to be a significant observation. There also seems to be very large differences between replicates of the evolved clones and ancestors in Figure 7---figure supplement 1/Figure 8---figure supplement 1 that should be commented on in the text as this is quite atypical for growth curves measurements of clones, in that there are more than two-fold differences in endpoint OD.

Of real interest is the evolution of cell death, however, cell death assays are based on only 5 clones and no population-level assay. The five clones include only two clones evolved in this experiment, (including ZDBp910 which is particularly sick in DM 0). Clones do not perform as well as populations in the growth assays, and it is reasonable to expect that clones do not perform as well as populations in the mortality assays. In other words, reliance on growth assays (Figure 3) does not provide knowledge of improvements in the population growth parameters that are evident in the population growth assays (Figure 2). Without carrying out population-based mortality assay, for multiple populations, it is not clear what trait has actually evolved in the population.

Strain ZDBp871 did not show improvement in DM0 and was worse in DM25, yet it was chosen for microscope analysis of cell death. Why were clones that showed large improvements included in the cell death analysis? It would be of major interest for the conclusions of the article to determine if there are strains that evolved reduced cell death. This seems like this is an unnecessary omission that could quite easily be fixed.

One of the claims that follows from the mortality experiments is that there is a mismatch between *E. coli* physiology and the citrate only environment. This is an interesting idea, and the discussion in paragraph four of the Discussion is compelling, but very speculative, with no data to support the idea of pleiotropy, tradeoffs or a relationship between cit^+^ and mortality, aside from the mortality assays in 5 clones.

The mortality assay measures the number of dead cells at stationary phase- cells die at a faster rate in stationary phase than log phase. Since the evolved clones have a reduced lag time, by the time you come to measure mortality these have been in stationary phase for longer than cells that have remained in log phase for a greater proportion of the 24hrs. Could this explain greater number of dead cells in evolved cit0?

It looks like every clone isolated from the LTEE has a high mortality rate- could it be that high mortality is a trait of the LTEE and not specific to cit^+^?

Essential revisions:

If time and resources were unlimited we would request the inclusion of population-based competitive fitness measures of all derived lines relative to the respective ancestor, plus calibration of OD against cell viability, and a more comprehensive set of cell death assays in order to support the claims of increased mortality.

Recognising that both time and resources are limited, plus the fact that there is much that is valuable in the paper, we urge the authors to consider the above requests, but in terms of required revisions, we insist solely on inclusion of additional cell death assays sufficient to bolster claims and address the concerns raised above. We think these can be done quickly.

Even with the addition of further analysis of experimental lines, we think it will likely be necessary to dial back claims about the evolution of increased mortality. We also think that in the absence of population measures of competitive fitness that limitations of the fitness measures should be clearly stated and discussed.

One addition request is to pay careful attention to the degree of repetition. The is opportunity to produce a more streamlined manuscript through removal of extraneous paragraphs and those that are repeated. For example, the Conclusion section is long and largely reads as a second discussion that repeats parts of the first. How about removing repeated sections and producing a succinct conclusion?
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Author response

> Major concerns:
>
> All reviewers were surprised to find that derived lines were not subject to standard population-level assays of competitive fitness. Instead, OD was used as a phenotypic measure of performance, sometimes with populations, but the more significant data came from analysis of individual clones. Reliance on OD, without calibration against viable cell counts, can result in misleading conclusions. Small differences in death, or cell size, all impact on OD.

We have now included results from 1-day competition assays using the evolved populations. Unfortunately, we were unable to conduct longer competitions due to the research shutdown caused by the pandemic. We have also included the results of 3-day competition assays on a subset of evolved clones (for which we isolated neutral Ara^+^/Ara^−^ mutants of their ancestors for comparison). We present these data in the revised text in a new subsection of the Results. We show the fitness data in Figures 3 and 4 of our revised manuscript. Jessica A. Baxter performed part of these competitions. We have in consequence added her as a co-author. The other authors of the manuscript have approved her addition and placement in the author list. We would also emphasize that we do not use OD per se as a measure of performance; rather, we use *rates of change* in OD to estimate some standard growth parameters. The inclusion of both competitive fitness assays and growth-parameter estimates should make the differences in these approaches clear.

> In a similar vein, Figure 6---figure supplement 1: Some populations (both ancestors and evolved strains) appear to reach a much higher OD. This receives no comment but it would appear to be a significant observation. There also seems to be very large differences between replicates of the evolved clones and ancestors in Figure 7---figure supplement 1/Figure 8---figure supplement 1 that should be commented on in the text as this is quite atypical for growth curves measurements of clones, in that there are more than two-fold differences in endpoint OD.

Large variations in the OD of replicate cultures of the same clone during growth curve measures are not unusual for Cit^+^ clones, and we reported similar variation in our previous publications. This variation has made it challenging to characterize their growth parameters and fitness. While such extreme variation in OD values is atypical of most study systems, it is entirely consistent with the several lines of evidence we present for a persistent mismatch between *E. coli* physiology and growth on citrate, as it implies the cells are extremely sensitive to subtle environmental fluctuations when growing on citrate. We now discuss these issues thoroughly in the revised text.

> Of real interest is the evolution of cell death, however, cell death assays are based on only 5 clones and no population-level assay. The five clones include only two clones evolved in this experiment, (including ZDBp910 which is particularly sick in DM 0). Clones do not perform as well as populations in the growth assays, and it is reasonable to expect that clones do not perform as well as populations in the mortality assays. In other words, reliance on growth assays (Figure 3) does not provide knowledge of improvements in the population growth parameters that are evident in the population growth assays (Figure 2). Without carrying out population-based mortality assay, for multiple populations, it is not clear what trait has actually evolved in the population.

We agree that our analyses of cell death would benefit from greater replication and scope. We planned additional experiments to look more closely at the phenomenon of cell death, but we were unable to conduct them before the COVID-19 pandemic necessitated a research hiatus. We think the fitness data we have included, especially those that show paradoxical fitness declines during evolution, are consistent with the cell-death data we have presented, and we discuss them in that context. Nonetheless, in the absence of follow-up experiments on cell death, we have tempered our claims on this issue. That said, it remains clear that, for at least some combinations of strains and environments, there is substantial cell death, which is indicative of the mismatch between *E. coli* physiology and growth on citrate.

> Strain ZDBp871 did not show improvement in DM0 and was worse in DM25, yet it was chosen for microscope analysis of cell death. Why were clones that showed large improvements included in the cell death analysis?

We chose these two evolved strains without considering (and prior to knowing) their growth characteristics. We designed this experiment as a simple demonstration of extensive death of Cit^+^ cells. We were motivated by some preliminary microscopy observations of many ghost-like cells, suggestive of mortality, in the original Cit^+^ LTEE population; those observations were made in the context of a separate (as yet unpublished) study on the evolution of cell size in the LTEE.

Our consideration was simply choosing one DM0-evolved clone (ZDBp871), one DM25-evolved clone, and their common ancestor, CZB151. We chose to use strains descended from CZB151 because the Ara^+^ derivative of that ancestor, ZDB67, has no secondary mutations. The absence of secondary mutations meant we could better relate the cell-mortality results to the fitness analyses of these same strains relative to their ancestor.

> It would be of major interest for the conclusions of the article to determine if there are strains that evolved reduced cell death. This seems like this is an unnecessary omission that could quite easily be fixed.

We agree that it would be interesting to find genotypes that evolved reduced death, if they exist. As explained above, we intend to carry out additional experiments on cell mortality in future work, but we are unable to do so at present due to the COVID-19 pandemic.

> One of the claims that follows from the mortality experiments is that there is a mismatch between *E. coli* physiology and the citrate only environment. This is an interesting idea, and the discussion in paragraph four of the Discussion is compelling, but very speculative, with no data to support the idea of pleiotropy, tradeoffs or a relationship between cit^+^ and mortality, aside from the mortality assays in 5 clones.

We are pleased that you found this discussion compelling, albeit speculative. Given our limited data on mortality, and the fact that we cannot perform further experiments at this time, we have eliminated the more speculative aspects of the discussion.

That said, our additional fitness results provide yet more evidence to support our hypothesis of a mismatch between *E. coli* cell physiology and the citrate-only environment. The variation among replicate fitness assays, the limited fitness gains even after 2,500 generations, the striking variability across replicate growth curves, and the heightened mortality in the Cit^+^ clones---all indicate that these bacteria struggle to grow normally on citrate. In future work, we will try to more rigorously examine the relationship between the Cit^+^ trait and mortality, and the possible role of pleiotropic tradeoffs.

> The mortality assay measures the number of dead cells at stationary phase- cells die at a faster rate in stationary phase than log phase. Since the evolved clones have a reduced lag time, by the time you come to measure mortality these have been in stationary phase for longer than cells that have remained in log phase for a greater proportion of the 24hrs. Could this explain greater number of dead cells in evolved cit0?

Thank you for these ideas. It would be interesting if cell death correlates with time spent in stationary phase (even over the relatively short duration of our growth curve experiments), and if the shorter lag phase could then account for increased death. We hope to answer this question in future experiments (once lab work can be safely resumed) with live/dead staining on samples taken at various stages of population growth. We have revised the text to present the cell-death results that we have for now in as straightforward a way as possible, to avoid possible over-interpretation.

> It looks like every clone isolated from the LTEE has a high mortality rate- could it be that high mortality is a trait of the LTEE and not specific to cit^+^?

Similar preliminary and unpublished live-dead staining performed on other LTEE populations indicates that elevated cell death is specific to the Cit^+^ phenotype, with little to no death occurring in Cit^--^strains. This inference is also supported by the observation (now mentioned in our revised paper) of many "ghost-like" cells only in the Cit^+^ population, which first raised the possibility of elevated cell death in this lineage. In addition, Vasi et al., 1994, directly estimated cell mortality (based on viable CFUs) during stationary phase for the ancestor and early-generation samples of all the LTEE populations, and found very little mortaility.

> Essential revisions:
>
> If time and resources were unlimited we would request the inclusion of population-based competitive fitness measures of all derived lines relative to the respective ancestor, plus calibration of OD against cell viability, and a more comprehensive set of cell death assays in order to support the claims of increased mortality.
>
> Recognising that both time and resources are limited, plus the fact that there is much that is valuable in the paper, we urge the authors to consider the above requests, but in terms of required revisions, we insist solely on inclusion of additional cell death assays sufficient to bolster claims and address the concerns raised above. We think these can be done quickly.

We were able to perform some of the recommended fitness assays, but we were unable to perform the requested cell-death experiments due to the closure of the lab caused by the COVID-19 pandemic.

> Even with the addition of further analysis of experimental lines, we think it will likely be necessary to dial back claims about the evolution of increased mortality.

We have tempered speculation concerning the evolution of increased cell mortality, presenting the results we have to date as straightforwardly as possible. We provide these data as one of several lines of evidence that cells grown on citrate suffer from substantial physiological stress.

> We also think that in the absence of population measures of competitive fitness that limitations of the fitness measures should be clearly stated and discussed.

We believe that the population-level fitness measures we now include satisfy this request.

> One addition request is to pay careful attention to the degree of repetition. The is opportunity to produce a more streamlined manuscript through removal of extraneous paragraphs and those that are repeated. For example, the Conclusion section is long and largely reads as a second discussion that repeats parts of the first. How about removing repeated sections and producing a succinct conclusion?

We have revised the manuscript specifically to remove repetition and extraneous paragraphs. In particular, we eliminated the Conclusion as a separate section, retaining some parts where it was more concise than the previous Discussion, largely deleting the preceding text, and editing the structure and organization. Thank you for this advice; we believe our revised paper is both shorter and clearer.

[^1]: These authors contributed equally to this work.
